International Journal of Immunotherapy and Cancer Research is a multi-disciplinary peer-reviewed, open access journal. Journal brings together all the varied aspects of research that will ultimately lead to the prevention of cancer. With the goal of advancing technology and improving healthRead more
CHA University, Republic of KoreaEmail: firstname.lastname@example.org
Research Interest: Molecular biology, cytogenetics, genotoxicity, micronucleus, cytome assay, mutagenicity tests, gene expression, human cancer, pituitary adenomas, obesity.
Research Interest: My research interest involves finding innovative gene therapy solutions for human diseases. At Bellicum, Pharmaceuticals, I have played a leading role in the discovery and pre-clinical development of the CIDeCAR and Go-CART product portfolios. Prior to Bellicum, I was a trainee at Baylor College of Medicine where I developed a novel platform for delivery of erythropoietin to treat anemia associated with chronic kidney disease and evaluated the safety of the piggyBac gene delivery system for gene and cell the rapy. I have extensive research experience in immunotherapy of leukemias and solid tumors, adoptive transfer of T cells, T cell biology, tumor infiltrating lymphocytes, immune receptors biology, antigen processing and recognition, antibody therapy, tumor immunology, viral and non-viral vectors, and gene therapy of monogeneic disorders. I have comprehensive knowledge of molecular biology research techniques including genetic engineering, vector design, cloning, transfection platforms,
cytometry, biomarker development and validation and synthetic DNA construction
Research Interest: signaling pathways, molecular studies and biosensor development for detection of cancer with the collaboration of nanotechnology experts.
Research Interest: Radiopharmaceutical development that involves radiolabeled agents and
their evaluations both in vitro and in vivo. These agents are for disease
detection, life process tracing, or tumor radiotherapy.
Research Interest: Research areas of human physiology and pathophysiology. His research focuses on the clinical evaluation of new biomarkers and molecular mediators in several pathophysiological disease states, such as diabetes, atherosclerosis and cancer. His research interest also includes the development of quantitative structure-activity relationships (QSARs) and quantitative structure-property relationships (QSPRs) in the area of toxicology and pharmacology. Furthermore, his research interest lies in the assessment of physicochemical properties, such as lipophilicity, solubility and ionization of drugs, natural bioactive compounds and toxic chemicals in relation with their potential biological activity and toxicity endpoints, as well as their Absorption/Distribution/Metabolism/Excretion (ADME) parameters and their pharmacokinetic and toxicokinetic profiles
Research Interest: Gut microbiology; Metabolic diseases; Mucosal Immunology; Cancer; Functional foods and Nutraceutical
• modelling, optimisation and control of biotechnological processes;
• drug design, molecular modelling, virtual ligand screening;
• metaheuristic algorithms;
• intuitionistic fuzzy logic;
• generalised nets;
• intercriteria analysis in decision making systems
Research Interest: His interests in liver fibrosis research focuses on the use of intrahepatic administration of collagenase for reversal of liver fibrosis and this work was one of the earliest that established proof-of-principle of these potential therapeutic agents. His immunological interest lies with double-stranded RNA induced immune response and its potential application in anti-virus and/or anti-cancer immunotherapy.
Research Interest: Cancer therapy, cancer stem cells, tumour biomarkers, suicide gene therapy and antitumoral drugs, nanotechnology and regenerative medicine.
Research Interest: Melanoma, kidney cancer , immunotherapy with ipilimumab, nivolumab, interleukin-2 and other agents.
Research Interest: Gynecologic oncology, chemotherapy, immunotherapy, targeted therapy, systemic therapy, Supportive therapy
Research Interest: Head and neck oncology, molecular as well as clinically molecular rhinology
Research Interest: My research interests are from basic immunology science to translational medicine in following immune associated area/diseases.
1. Cancer Immunology and nano-medicine
2. Obesity and Immunity
3. Neuro-immunology (autoimmune induced central nervous system inflammation)
4. Immunity to Infectious Diseases and Vaccines
Research Interest: Thoracic Oncology, Translational Research, Immuno-Oncology
Research Interest: Development of new DNA vaccines and adjuvants for anticancer therapy and/or prevention, intended for clinical application. Preclinical protocols of genetic immunization against tumor-associated antigens Combined therapeutic protocols (vaccination+immunotherapy+chemotherapy) in preclinical research.
Published On: May 20, 2017 | Pages: 032 - 033View Article DOI: 10.17352/2455-8591.000016
Published On: April 17, 2017 | Pages: 019 - 031View Article DOI: 10.17352/2455-8591.000015
Published On: March 31, 2017 | Pages: 015 - 018View Article DOI: 10.17352/2455-8591.000014
Published On: February 03, 2017 | Pages: 012 - 014View Article DOI: 10.17352/2455-8591.000013
Published On: February 01, 2017 | Pages: 007 - 011View Article DOI: 10.17352/2455-8591.000012
Published On: February 01, 2017 | Pages: 001 - 006View Article DOI: 10.17352/2455-8591.000011
Published On: December 31, 2016 | Pages: 014 - 016View Article DOI: 10.17352/2455-8591.000010
Published On: October 06, 2016 | Pages: 011 - 013View Article DOI: 10.17352/2455-8591.000009
Published On: June 17, 2016 | Pages: 003 - 010View Article DOI: 10.17352/2455-8591.000008